| 2002 |
TgMyoA is a fast, single-headed, plus-end-directed motor that moves actin filaments in unitary steps of 5.3 nm at a velocity of 5.2 µm/s, as established by microneedle-laser trap and sliding velocity assays. TgMyoA binds a novel myosin light chain TgMLC1 and is anchored at the plasma membrane. |
In vitro motility assay, microneedle-laser trap (optical tweezers), biochemical characterization of purified motor complex |
The EMBO journal |
High |
11980712
|
| 2002 |
Conditional removal of MyoA using a tetracycline-inducible system caused severe impairment in host cell invasion and parasite spreading in cultured cells, and established MyoA as essential for pathogenesis in an animal model. |
Tetracycline-inducible conditional gene disruption (regulatable transactivator system), cell invasion assays, animal model infection |
Science |
High |
12399593
|
| 2001 |
Overexpression of a MyoA transgene drastically down-regulates the level of endogenous MyoA, indicating MyoA is under tight feedback regulation at the protein level. |
Tetracycline-inducible expression system, Western blot analysis of endogenous protein levels |
Nucleic acids research |
Medium |
11713335
|
| 2004 |
TgMyoA forms a protein complex with its light chain TgMLC1 and two novel proteins TgGAP45 and TgGAP50. This complex is localized to the inner membrane complex, where it is anchored by TgGAP50, an integral membrane glycoprotein. Complex assembly is spatially controlled and occurs in two stages. |
Co-immunoprecipitation, subcellular fractionation, immunofluorescence localization, identification of novel complex components |
The Journal of cell biology |
High |
15123738
|
| 2010 |
The glideosome contains MyoA, MLC1, GAP45, GAP50, and a newly identified polytopic IMC protein GAP40. GAP45 is anchored to the plasma membrane and IMC via its N- and C-terminal extremities respectively; its C-terminal region recruits MLC1-MyoA to the IMC. GAP45 is essential for gliding, invasion, and egress. |
Conditional knockdown, co-immunoprecipitation, immunofluorescence, complementation experiments including transgenera complementation with P. falciparum GAP45 |
Cell host & microbe |
High |
20951968
|
| 2008 |
Phosphorylation of GAP45 at Ser163 and Ser167 controls the final step of MyoA motor complex assembly: phosphomimetic mutations (Ser-to-Glu) prevent association of the MyoA-MLC1-GAP45 subcomplex with the membrane anchor GAP50, while alanine mutations do not affect assembly. |
Mass spectrometry identification of phosphorylation sites, site-directed mutagenesis (Ser-to-Glu and Ser-to-Ala), co-immunoprecipitation |
Eukaryotic cell |
High |
19047362
|
| 2011 |
Calcium-dependent phosphorylation of six residues across GAP45, MLC1, and MyoA correlates with invasion motor activity. A novel 15-kDa calmodulin-like protein (MyoA Essential Light Chain) associates more strongly with the invasion motor upon calcium stimulation, identifying a new regulatory component. |
SILAC-based quantitative LC-MS/MS phosphoproteomics, 2-DE of 32P-labeled protein extracts, calcium stimulation experiments |
PLoS pathogens |
Medium |
21980283
|
| 2010 |
Post-translational modification of TgMLC1 by a small-molecule inhibitor (tachyplegin) causes decreased TgMyoA motor activity, as shown by in vitro motility assay comparing motor complexes from treated vs. untreated parasites. This established that Class XIV myosin motor activity can be modulated by PTMs on its associated light chain. |
In vitro motility assay with purified motor complexes, electrophoretic mobility shift, peptide mapping |
PLoS pathogens |
High |
20084115
|
| 2014 |
TgMyoA undergoes calcium-dependent phosphorylation; a small-molecule enhancer of motility (compound 130038) causes increased intracellular calcium leading to increased TgMyoA phosphorylation. Parasites expressing nonphosphorylatable mutant MyoA egressed from host cells more slowly in response to calcium ionophore, demonstrating that calcium-dependent phosphorylation of MyoA modulates myosin-driven processes. |
Site-directed mutagenesis of phosphorylation sites, calcium ionophore treatment, egress assays, compound treatment, intracellular calcium measurement |
Molecular biology of the cell |
High |
24989796
|
| 2015 |
TgCDPK3 phosphorylates TgMyoA at Ser21 and Ser743 in vitro. Complementation of a myoA null mutant with MyoA bearing S21A or S743A alanine mutations failed to rescue the egress delay phenotype, while phosphomimetic mutations bypassed the need for TgCDPK3. This establishes TgCDPK3-mediated phosphorylation of TgMyoA as the mechanism for rapid initiation of motility and egress. |
BioID proximity interaction screen, peptide array kinase assay in vitro, genetic complementation with phosphomimetic/alanine mutants, egress assays |
PLoS pathogens |
High |
26544049
|
| 2014 |
MyoA and its associated motor complex (MLC1, GAP45, Act1) are important but not absolutely essential for gliding motility and host cell invasion; conditional KO mutants remain invasive, suggesting alternative invasion mechanisms exist alongside the MyoA-glideosome. |
Conditional knockout of MyoA, MLC1, GAP45, Act1; invasion and motility assays |
PloS one |
Medium |
24632839
|
| 2014 |
Deletion of MyoA leads to relocalization of MyoC along the pellicle and at the apical cap, accounting for residual invasion. MyoA and MyoC glideosomes exhibit plasticity, with MyoC-glideosome providing functional compensation for loss of MyoA. |
Conditional knockout of MyoA, immunofluorescence localization of MyoC, invasion assays |
PLoS pathogens |
Medium |
25393004
|
| 2015 |
Two essential light chains (ELC1 and ELC2) bind the MyoA lever arm and are functionally redundant but important for invasion, egress, and motility. Ca2+ promotes intermolecular contacts between ELCs and the adjacent MLC1 to stabilize the lever arm domain, as demonstrated by point mutations predicted to ablate Ca2+ binding or the ELC-MLC1 interface. |
Identification of ELC2 by database search, conditional knockdown, molecular dynamics simulations, point mutagenesis, gliding motility assays |
mBio |
Medium |
26374117
|
| 2014 |
TgMyoA expressed in Sf9 cells requires a parasite-specific UCS-family co-chaperone (TgUNC) to be soluble and functional. The MyoA heavy chain with only MLC1 moves actin at ~1.5 µm/s, but addition of ELC1 increases speed to ~3.4 µm/s, demonstrating that two light chains bound to the lever arm are required for fast motility. |
Baculovirus/Sf9 heterologous expression, in vitro actin gliding motility assay, co-expression of chaperone and light chains |
The Journal of biological chemistry |
High |
25231988
|
| 2018 |
The 2.6-Å crystal structure of the TgMyoA motor domain reveals a divergent SH1/SH2 region and class-defining 'HYAG'-site polymorphism as key structural elements for force transduction and chemomechanical coupling. Hydrogen-deuterium exchange MS showed that phosphorylation-dependent enhanced motility correlates with increased local stability in specific regions of the motor. Solvent-accessible pockets differ from human myosins, supporting inhibitor design. |
X-ray crystallography (2.6 Å), hydrogen-deuterium exchange coupled to MS, in vitro motility assay with phosphorylation variants |
Proceedings of the National Academy of Sciences of the United States of America |
High |
30348763
|
| 2017 |
MLC1 and ELC1 bind adjacent sites on the MyoA neck (residues 775–818). The 1.85-Å crystal structure of MLC1 bound to its MyoA peptide shows a bilobed architecture with MLC1 clamping around the helical peptide (Kd ~10 nM). Ca2+ coordination by an EF-hand in ELC1 and pre-binding of MLC1 cooperate to increase ELC1 affinity for the neck 49-fold, to ~12 nM. ELC1 also engages the MyoA converter subdomain. |
X-ray crystallography (1.85 Å), hydrogen-deuterium exchange MS, isothermal titration calorimetry, binding affinity measurements |
The Journal of biological chemistry |
High |
28972141
|
| 2020 |
Crystal structures of ELC in trimeric sub-complexes with MyoA show that ELCs bind a conserved MyoA sequence and induce secondary structure in MyoA to stiffen its lever arm. Structural and biophysical analysis reveals that calcium binding has no influence on ELC structure. |
X-ray crystallography of trimeric sub-complexes, biophysical analysis (SPR/ITC) |
Communications biology |
High |
33051581
|
| 2016 |
MyoH is indispensable for translocation of the circular junction from the parasite tip to the apical IMC position; once this first step is accomplished, MyoA relays the process to enact effective gliding and invasion along the pellicle. This establishes a sequential handoff between MyoH (conoid-anchored) and MyoA (IMC-anchored) during motility. |
Conditional disruption of TgMyoH, immunofluorescence, invasion and egress assays, epistasis between MyoH and MyoA |
PLoS pathogens |
Medium |
26760042
|
| 2017 |
Parasites with mlc1 cKO (and act1 cKO) are virtually unable to attach to a collagen-coated substrate under flow conditions while retaining residual motility at wildtype speed, demonstrating that the actomyosin system (including MyoA via MLC1) functions primarily in surface attachment rather than as the sole force generator for movement. |
Conditional knockout of mlc1 and act1, 3D motility assays, substrate attachment assays under flow, comparison of mutant phenotypes |
BMC biology |
Medium |
28100223
|
| 2014 |
TgMLC1 C58 is the direct covalent target of tachypleginA and its analogues, as demonstrated by click chemistry labelling. A C58S recombinant TgMLC1 mutation is refractory to compound binding, and knock-in parasites expressing C58S show decreased sensitivity to compound-induced motility inhibition, confirming TgMLC1 as the mechanistic target mediating inhibition of TgMyoA motor activity. |
Click chemistry labelling with alkyne-derivatized inhibitor, site-directed mutagenesis (C58S, S57A), knock-in parasite line, 3D motility assay |
PloS one |
High |
24892871
|
| 2023 |
A small-molecule inhibitor KNX-002 inhibits TgMyoA actin-activated ATPase activity in vitro with little effect on vertebrate myosins. A resistance mutation T130A in TgMyoA reduces compound sensitivity both in biochemical and parasite assays, validating TgMyoA as a druggable target in vivo and establishing that KNX-002 slows disease progression in mice through on-target MyoA inhibition. |
High-throughput screen of 50,000 compounds for ATPase inhibition, chemical mutagenesis + selection, targeted sequencing, in vitro motility assay, mouse infection model with wild-type vs. T130A parasites |
PLoS biology |
High |
37155705
|
| 2024 |
MyoA accumulates around the mitochondrion in late stages of parasite division (ultrastructure expansion microscopy). Parasites lacking MyoA show defective mitochondrial morphology and delay in mitochondrion delivery to daughter buds during division, establishing a role for MyoA in organellar inheritance beyond gliding motility. Mitochondrion vesicles extracted from parasites interact with actin filaments. |
Ultrastructure expansion microscopy (U-ExM), conditional MyoA knockdown, mitochondrion morphology and inheritance assays, actin pulldown with mitochondrion vesicles, yeast two-hybrid (LMF1-MyoA interaction identified) |
PLoS pathogens |
Medium |
39374269
|
| 2020 |
The acto-MyoA motor directs traction force during tachyzoite helical gliding; traction force microscopy and reflection interference microscopy revealed a critical apical anchoring adhesion that stores energy via microtubule cytoskeleton and sets thrust force for helical gliding. |
Quantitative traction force microscopy, reflection interference microscopy, micropatterning, expansion microscopy |
ACS nano |
Medium |
32432851
|